EMILIE GROSHEIM: Open Payments
NPI 1477913218 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 25 payments from 14 companies in 2025. Trend: 2023 $1,029 · 2024 $288 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $96 |
| Abbott Laboratories | 3 | $73 |
| Corcept Therapeutics | 3 | $64 |
| Lilly USA, LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $36 |
| Medtronic, Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, Korlym, MOUNJARO, Dexcom G6 Transmitter, JARDIANCE, OPSUMIT, MINIMED 780G.
Industry payments across OH — which companies pay providers there.
